Online inquiry

IVTScrip™ mRNA-Human ARL4A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26841MR)

This product GTTS-WK26841MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARL4A protein. This product can be used in Oligodendrocyte-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001037164.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10124
UniProt ID P40617
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL4A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26841MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK15219MR IVTScrip™ mRNA-Human ANKRD36, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD36
GTTS-WK14930MR IVTScrip™ mRNA-Human ANKRD50, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD50
GTTS-WK4127MR IVTScrip™ mRNA-Human CD24, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CD24
GTTS-WK27763MR IVTScrip™ mRNA-Human ARNTL, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARNTL
GTTS-WK14178MR IVTScrip™ mRNA-Human ABLIM1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABLIM1
GTTS-WK25932MR IVTScrip™ mRNA-Human ARL1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARL1
GTTS-WK7738MR IVTScrip™ mRNA-Human ADGRE3, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADGRE3
GTTS-WK24704MR IVTScrip™ mRNA-Human ARHGDIA, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGDIA
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →